# NCT05501704 (NCT05501704)

> ETHAN - ET for Male BC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05501704
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Jose Pablo Leone
- Conditions: Male Breast Cancer; Hormone Receptor-positive Breast Cancer; Hormone Receptor Negative Breast Carcinoma
- Interventions: Tamoxifen; Anastrozole; Degarelix; Abemaciclib
- Enrollment: 60
- Primary outcome: Change in Ki-67
- Primary outcome: RCB index

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct05501704